Metropolis Healthcare’s (Metropolis) reported Q2FY23 performance was broadly in line with our estimates. Revenue remained flat YoY (+7.3% QoQ) at Rs3bn (I- Sec: Rs3.1bn) on a high base which had benefited from covid-related business.